Volume 22, Number 8—August 2016
Research
Enterovirus D68 Infection in Children with Acute Flaccid Myelitis, Colorado, USA, 2014
Negar Aliabadi
, Kevin Messacar, Daniel M. Pastula, Christine C. Robinson, Eyal Leshem, James Sejvar, W. Allan Nix, M. Steven Oberste, Daniel R. Feikin, and Samuel R. Dominguez
, Kevin Messacar, Daniel M. Pastula, Christine C. Robinson, Eyal Leshem, James Sejvar, W. Allan Nix, M. Steven Oberste, Daniel R. Feikin, and Samuel R. Dominguez
Table 2
EV-D68 and EV/RV association with acute flaccid myelitis compared with RPP-tested controls, Colorado, USA, 2014*
| Model | RPP-tested controls |
|
|---|---|---|
| Unadjusted models, OR (95% CI) | Adjusted models, OR (95% CI) | |
| EV-D68 | 9.1 (1.9–42.0)† | 10.3 (1.8–64.8)‡ |
| Patient age | NA | 1.0 (0.9–1.2) |
| Time to specimen collection | NA | 1.1 (1.0–1.2) |
| Epidemiologic wk of specimen collection |
NA |
0.9 (0.7–1.3) |
| EV/RV excluding EV-D68 | 4.5 (0.8–23.9)§ | 6.9 (0.8–66.0)¶ |
| Patient age | NA | 1.1 (0.9–1.3) |
| Time to specimen collection | NA | 1.1 (1.0–1.2) |
| Epidemiologic wk of specimen collection | NA | 0.9 (0.6–1.2) |
*Denominators vary slightly within models because some observations were missing for covariates. EV, enterovirus; NA, not applicable; OR, odds ratio; RPP, respiratory pathogen panel; RV, rhinovirus.
†n = 105.
‡n = 102.
§n = 99.
¶n = 96.
Page created: July 15, 2016
Page updated: July 15, 2016
Page reviewed: July 15, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.